Aridis Pharmaceuticals Inc (NASDAQ:ARDS)
| 0.2945 BATS BZX Real-Time Price As of 3:43pm ET |  +0.0134 / +4.77%Today’s Change | 0.15 Today|||52-Week Range 2.77 | -75.04% Year-to-Date |
Five Year Financial Summary
| All Currency in US Dollars | 4 Year Trend | |||||
|---|---|---|---|---|---|---|
2015 | 2016 | 2017 | 2018 | |||
| Revenue and Income | Net Revenues | 2.9M | 2.3M | 860.0K | 2.8M | |
| Cost of Goods Sold | 2.1M | 1.9M | 0.00 | -- | ||
| Depreciation And Amortization | 27.0K | 23.0K | 62.0K | 281.0K | ||
| Operating Expenses | Gross Income | 714.0K | 342.0K | 798.0K | -- | |
| General Expenses | 8.6M | 8.2M | 20.5M | 26.6M | ||
| Research And Development | 5.3M | 6.3M | 17.4M | 23.0M | ||
| Total Operating Expenses | 10.8M | 10.2M | 20.6M | 26.9M | ||
| Non-Operating Expenses | Operating Income | -7.9M | -7.9M | -19.7M | -24.1M | |
| Extraordinary Credit | 0.00 | 0.00 | 0.00 | 1.6M | ||
| Extraordinary Charge | 0.00 | -172.0K | -5.2M | 0.00 | ||
| Pre-Tax Equity Earnings | 0.00 | 0.00 | 0.00 | -40.0K | ||
| Interest Expense On Debt | 296.0K | 366.0K | -- | 0.00 | ||
| Income Taxes, Minority Interest and Extra Items | Pre-Tax Income | -8.2M | -8.4M | -24.7M | -22.1M | |
| Preferred Dividend | 0.00 | -465.0K | -2.8M | -1.4M | ||
| Net Income | -8.2M | -8.4M | -24.7M | -22.1M | ||
| Shares To Calculate EPS | Shares To Calculate EPS | 8.2M | 8.2M | 8.2M | 3.1M | |
| Shares To Calculate EPS Diluted | 8.2M | 8.2M | 8.2M | 3.1M | ||
| Earnings Per Share | EPS | -$1.00 | -$1.09 | -$3.35 | -$7.45 | |
| EPS Diluted | -$1.00 | -$1.09 | -$3.35 | -$7.46 | ||
